Arkolith/Insider Trading/ATRA/Form 4

Adiumentum Capital Fund I GP LLC

Director, 10% OwnerAtara Biotherapeutics, Inc. (ATRA) · full profile →Form 4 · filed May 16, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 16, 2025Grant(A)76K$6.61$500K1.2M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 16, 2025Grant(A)227K$6.61$1.5M377K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-050116) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML